BioCentury
ARTICLE | Company News

Alderon Biosciences Inc., Magellan Bio deal

May 14, 2007 7:00 AM UTC

Magellan acquired undisclosed IP from Alderon for developing assays to detect metals, nucleic acids, proteins and small molecules. Magellan markets rapid point-of-care analyzers and automated systems ...